Radiosurgery for brain metastases: relationship of dose and pattern of enhancement to local control
CY Shiau, PK Sneed, HKG Shu, KR Lamborn… - International Journal of …, 1997 - Elsevier
Purpose : This study aimed to analyze dose, initial pattern of enhancement, and other factors
associated with freedom from progression (FFP) of brain metastases after radiosurgery (RS)…
associated with freedom from progression (FFP) of brain metastases after radiosurgery (RS)…
Diagnosis and treatment of recurrent high-grade astrocytoma
NA Butowski, PK Sneed, SM Chang - Journal of clinical oncology, 2006 - ascopubs.org
High-grade gliomas represent a significant source of cancer-related death, and usually
recur despite treatment. In this analysis of current brain tumor medicine, we review diagnosis, …
recur despite treatment. In this analysis of current brain tumor medicine, we review diagnosis, …
[HTML][HTML] Summary report on the graded prognostic assessment: an accurate and facile diagnosis-specific tool to estimate survival for patients with brain metastases
… Sneed, Samuel T. Chao, John Suh, Amit Bhatt, Ashley W. Jensen,Paul D. … Sneed,
University of California, San Francisco, San Francisco, CA; Zhiyuan Xu, Samuel T. Chao …
University of California, San Francisco, San Francisco, CA; Zhiyuan Xu, Samuel T. Chao …
Diagnosis-specific prognostic factors, indexes, and treatment outcomes for patients with newly diagnosed brain metastases: a multi-institutional analysis of 4,259 …
PURPOSE: Controversy endures regarding the optimal treatment of patients with brain
metastases (BMs). Debate persists, despite many randomized trials, perhaps because BM …
metastases (BMs). Debate persists, despite many randomized trials, perhaps because BM …
A multi-institutional experience with stereotactic radiosurgery for solitary brain metastasis
…, R Weiner, GR Harsh IV, PK Sneed… - International Journal of …, 1994 - Elsevier
Purpose : A multi-institutional experience in radiosurgery for solitary brain metastases was
combined to identify factors associated with safety, efficacy, tumor control, and survival. …
combined to identify factors associated with safety, efficacy, tumor control, and survival. …
A multi-institutional review of radiosurgery alone vs. radiosurgery with whole brain radiotherapy as the initial management of brain metastases
PK Sneed, JH Suh, SJ Goetsch, SN Sanghavi… - International Journal of …, 2002 - Elsevier
Purpose : Data collected from 10 institutions were reviewed to compare survival probabilities
of patients with newly diagnosed brain metastases managed initially with radiosurgery (RS) …
of patients with newly diagnosed brain metastases managed initially with radiosurgery (RS) …
Survival benefit of hyperthermia in a prospective randomized trial of brachytherapy boost±hyperthermia for glioblastoma multiforme
PK Sneed, PR Stauffer, MW McDermott… - International Journal of …, 1998 - Elsevier
… boost k hyperthermia for glioblastoma l PK SNEED it ,ri. … Brachytherapy boost -C hyperthermia
for glioblastoma l PK SNEED … Brachytherapy boost i hypetthennia for glioblastoma l PK S-…
for glioblastoma l PK SNEED … Brachytherapy boost i hypetthennia for glioblastoma l PK S-…
Radiosurgery for brain metastases: is whole brain radiotherapy necessary?
PK Sneed, KR Lamborn, JM Forstner… - International Journal of …, 1999 - Elsevier
Purpose: Because whole brain radiotherapy (WBRT) may cause dementia in long-term
survivors, selected patients with brain metastases may benefit from initial treatment with …
survivors, selected patients with brain metastases may benefit from initial treatment with …
Meningioma DNA methylation groups identify biological drivers and therapeutic vulnerabilities
…, NAO Bush, JD Schulte, N Butowski, PK Sneed… - Nature …, 2022 - nature.com
Meningiomas are the most common primary intracranial tumors. There are no effective
medical therapies for meningioma patients, and new treatments have been encumbered by …
medical therapies for meningioma patients, and new treatments have been encumbered by …
[HTML][HTML] Phase II study of erlotinib plus temozolomide during and after radiation therapy in patients with newly diagnosed glioblastoma multiforme or gliosarcoma
…, J Rabbitt, M Page, A Fedoroff, PK Sneed… - Journal of Clinical …, 2009 - ncbi.nlm.nih.gov
Purpose This open-label, prospective, single-arm, phase II study combined erlotinib with
radiation therapy (XRT) and temozolomide to treat glioblastoma multiforme (GBM) and …
radiation therapy (XRT) and temozolomide to treat glioblastoma multiforme (GBM) and …